Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2009
03/26/2009WO2004097028A3 Discovery of biocatalysts and biocatalytic activities using nuclear magnetic resonance and deuterium
03/26/2009WO2004096993A3 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
03/26/2009WO2004087871A3 Method of determining gene expression: targeted expressed gene display
03/26/2009WO2004064612A3 Regulation of tgf-b signaling by tomoregulin
03/26/2009WO2003070158A3 Therapeutic compositions and methods useful in modulating protein tyrosine phosphatases
03/26/2009US20090083877 Transcription Factors, DNA and Methods for Introduction of Value-Added Seed Traits and Stress Tolerance
03/26/2009US20090083873 Sequence-specific inhibition of small rna function
03/26/2009US20090083869 Methods and compositions for identifying agents that inhibit an ns4b-mediated neoplastic cellular phenotype of hcv infected cells
03/26/2009US20090083868 Increasing lifespan by modulation of WWP-1 and UBC-18
03/26/2009US20090082975 Method of selecting an active oligonucleotide predictive model
03/26/2009US20090082717 Dermal micro-organs, methods and apparatuses for producing and using the same
03/26/2009US20090082556 siRNA targeting TATA box binding protein (TBP)-associated factor (TAF1)
03/26/2009US20090082435 Methods, Compositions, And Compounds For Modulation Of Monoacylglycerol Lipase, Pain, And Stress-Related Disorders
03/26/2009US20090082424 Small molecule antagonists of bcl-2 family proteins
03/26/2009US20090082410 Constitutively translocating cell line
03/26/2009US20090082402 Methods of treating genitourinary disorders using inhibitors of soluble epoxide hydrolase
03/26/2009US20090082360 Use of tyrosine kinase inhibitors for treating CNS disorders
03/26/2009US20090082330 Certain substituted amides, method of making, and method of use thereof
03/26/2009US20090082304 Methods of Treating Hematological Malignancies with Nucleoside Analog Drugs
03/26/2009US20090082303 Drug for preventing and treating atherosclerosis
03/26/2009US20090082302 Modulation of eif4e-bp2 expression
03/26/2009US20090082300 Modulation of transthyretin expression
03/26/2009US20090082298 Methods for producing microRNAs
03/26/2009US20090082297 Compositions and Methods for Regulating Gene Expression
03/26/2009US20090082296 Mycobacterial antigens expressed during latency
03/26/2009US20090082273 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof
03/26/2009US20090082265 Compositions and methods for treating diseases
03/26/2009US20090082264 123 Human Secreted Proteins
03/26/2009US20090082251 Mitochondrial DNA variants associated with metabolic syndrome
03/26/2009US20090082250 Control of gene expression using a complex of an oligonucleotide and a regulatory peptide
03/26/2009US20090082225 Nucleic acid archiving
03/26/2009US20090082223 Method and kit for the determination of cellular activation profiles
03/26/2009US20090082215 Gene expression profiling from ffpe samples
03/26/2009US20090082214 Conjugate probes and optical detection of analytes
03/26/2009US20090082212 System and methods for nucleic acid sequencing of single molecules by polymerase synthesis
03/26/2009US20090081792 Immune potentiating compositions of cancer cells
03/26/2009US20090081788 Nucleotide sequence encoding the enzyme I-SceI and the uses thereof
03/26/2009US20090081780 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase
03/26/2009US20090081764 Heterologous G protein coupled receptors expressed in yeast, their fusion with G proteins and use thereof in bioassay
03/26/2009US20090081753 Method for formulating and immobilizing a matrix protein and a matrix protein for use in a sensor
03/26/2009US20090081736 Methods For Using Mutant RNA Polymerases Wtih Reduced Discrimination Between Non-Canonical Nucleoside Triphosphates
03/26/2009US20090081729 Compositions and Methods Comprising a Ligand of ChemerinR
03/26/2009US20090081728 Production of attenuated negative stranded rna virus vaccines from cloned nucleotide sequences
03/26/2009US20090081724 identifying a subject predisposed to a disorder associated with ion channel dysfunction; epilepsy; isolated nucleic acid molecule encoding a mutant or variant ion channel subunit
03/26/2009US20090081722 Site-specific labeling of affinity tags in fusion proteins
03/26/2009US20090081721 High-throughput cell assays
03/26/2009US20090081720 Methods for identifying stem cells based on nuclear morphotypes
03/26/2009US20090081719 Biochemical markers for acute pulmonary embolism
03/26/2009US20090081718 Protein cleavage method and thereof
03/26/2009US20090081717 Compositions and Methods For Signal Generation
03/26/2009US20090081716 Method for Monitoring the Immune Response and Predicting Clinical Outcomes in transplant recipients
03/26/2009US20090081715 Engineered Light-Emitting Reporter Genes
03/26/2009US20090081713 Peptide biomarkers predictive of renal function decline and kidney disease
03/26/2009US20090081705 Novel peptides and compositions which modulate apoptosis
03/26/2009US20090081699 Using protein phosphorylation profiles as evaluative tool in diagnosing/prognosing cell proliferative disorders
03/26/2009US20090081691 Transfecting a eukaryotic cell with nucleotide sequence, contacting cell with a candidate compound; determining distribution of expressed protein in cell by detecting the distribution of detectable moiety in cell; drug screening for their ability to interact with transmembrane proteins
03/26/2009US20090081689 Reagents and methods to enrich rare cells from body fluids
03/26/2009US20090081688 Methods of detecting nucleic acids in individual cells and of identifying rare cells from large heterogeneous cell populations
03/26/2009US20090081687 Nucleic Acid Molecules and Other Molecules Associated with Plants
03/26/2009US20090081686 Photocleavable labeled nucleotides and nucleosides and methods for their use in dna sequencing
03/26/2009US20090081685 Methods and compositions for the detection of ovarian disease
03/26/2009US20090081684 sequence-selective nucleic acid detection; polythiophenes containing pendant quaternary ammonium groups that are thermostable and autoclavable; use in DNA or RNA electrochemical or optical detection, or purification; diagnosis of infections or disease
03/26/2009US20090081683 Kits and Methods for Assessing the Coenzyme Q Reducing Status of a Patient, Including a Patient Ingesting a Statin
03/26/2009US20090081682 High-throughput methods for identifying gene function using lentiviral vectors
03/26/2009US20090081681 Method For Genetic Selection Of High-Plasmid Producing E. Coli Clones
03/26/2009US20090081680 Mutant firefly luciferase
03/26/2009US20090081679 Compositions and methods for in vivo SELEX
03/26/2009US20090081678 Nucleic acid isolation in preserved whole blood
03/26/2009US20090081677 Method for gender identification of eagles with probe-based real-time pcr and the sequences used for gender identification of eagles
03/26/2009US20090081676 Identifying polymerase chain reaction primer extension products using fluorescence energy transfer (FET); detecting allelic variation/restriction fragment length polymorphisms
03/26/2009US20090081675 Methods, compounds and systems for detecting a microorganism in a sample
03/26/2009US20090081674 Methods for Analysis of PDEF and Survivin as Interconnected Cancer Biomarkers and Targets for Personalized Medicine
03/26/2009US20090081673 Platensimycin biosynthetic gene cluster of streptomyces platensis
03/26/2009US20090081672 Testing by immunoassay for overexpression which is an indicator of breast cancer; relates to cDNA sequences from a region of amplification on chromosome 20 associated with disease. used in hybridization methods for the identification of chromosomal abnormalities
03/26/2009US20090081671 Method and apparatus for judging the presence or absence of cancer cell
03/26/2009US20090081670 Nicking and extension amplification reaction for the exponential amplification of nucleic acids
03/26/2009US20090081669 Fluorescent Assays Using Orthogonal tRNA - Aminoacyl Synthetase Pairs
03/26/2009US20090081668 Glycosyltransferase, nucleic acid encoding the glycosyltransferase and method of testing canceration using the nucleic acid
03/26/2009US20090081667 Viral Variants With Altered Susceptibility To Nucleoside Analogs And Uses Thereof
03/26/2009US20090081666 Probe set, probe carrier, and method for determining and identifying fungus
03/26/2009US20090081665 Using lipoprotein lipase (LPL) and/or a disintegrin and metalloproteinase 29 (ADAM29) expression as evaluative indicator of cell proliferative and lipoprotein metabolism disorders
03/26/2009US20090081664 Method for detecting reaction product of nucleic acid synthesis
03/26/2009US20090081663 Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
03/26/2009US20090081662 Homogeneous Luminescence Bioassay
03/26/2009US20090081661 Alkyl amines improve detection of components of formaldehyde-fixed biological samples
03/26/2009US20090081660 Compositions and methods for the diagnosis and treatment of tumor
03/26/2009US20090081659 Reagents for the detection of protein phosphorylation in carcinoma signaling pathways
03/26/2009US20090081658 Genemap of the human genes associated with crohn's disease
03/26/2009US20090081657 Genetic Identification And Validation Of Echinacea Species
03/26/2009US20090081656 Method for detecting a bacterial pathogen
03/26/2009US20090081655 Multiplex Real-time Quantitative PCR
03/26/2009US20090081654 Transfection kinetics and structural promoters
03/26/2009US20090081653 A nucleic acid regulating the expression of a gene responsive to insulin where the nucleic acid hybridizes under moderate stringency conditions to a hybridization probe; obesity; insulin-resistance syndrome; antidiabetic and -proliferative
03/26/2009US20090081652 Constitutively Translocating Cell Line
03/26/2009US20090081651 METHODS FOR ISOLATING AND CHARACTERIZING ENDOGENOUS mRNA-PROTEIN (mRNP) COMPLEXES
03/26/2009US20090081650 Method for Identifying Nucleotide Sequences, Use of the Method and Test Kit
03/26/2009US20090081649 Diagnostic method for detecting cancer by measuring amount of cytokine like il -6
03/26/2009US20090081648 Detection and analysis of influenza virus
03/26/2009US20090081647 Detection of a genetic predisposition to cancers and non-cancerous pathologies in mammals
03/26/2009US20090081646 Universal primers and their use for detecting and identifying plant materials in complex mixtures